The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability (Q40815251)

24 September 2017

title

The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability (English)

1 reference

24 September 2017

Mackay RI

1

1 reference

24 September 2017

Hendry JH

series ordinal

2

1 reference

24 September 2017

language of work or name

1 reference

1 January 1999

1 reference

Radiotherapy and Oncology

24 September 2017

published in

1 reference

24 September 2017

volume

50

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

67-75

1 reference

Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Steepness of the Clinical Dose–control Curve and Variation in thein VitroRadiosensitivity of Head and Neck Squamous Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Radiobiological considerations in the design of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Relationship between early and late normal-tissue injury after postmastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Low dose-rate fibroblast radiosensitivity and the prediction of patient response to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Radiosensitivity in cultured human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Evidence for a Positive Correlation betweenin VitroRadiosensitivity of Normal Human Skin Fibroblasts and the Occurrence of Subcutaneous Fibrosis after Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Survival of human diploid skin fibroblasts from normal individuals after X-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Haemopoietic injury after irradiation: analysis of dose responses and repair using a target-cell model.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900132-7

7 January 2021

10.1016/S0167-8140(98)00132-7

Identifiers

DOI

1 reference

24 September 2017

1 reference